{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:37:37Z","timestamp":1790339857664,"version":"4.1.0"},"reference-count":10,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006473","name":"Ministerio de Ciencia Tecnolog\u00eda y Telecomunicaciones","doi-asserted-by":"publisher","award":["MINECO SAF2017-83267-C2-1-R"],"award-info":[{"award-number":["MINECO SAF2017-83267-C2-1-R"]}],"id":[{"id":"10.13039\/501100006473","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2020,1,13]]},"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:p>Intratumoral delivery of viruses and virus-associated molecular patterns can achieve antitumor effects that are largely mediated by the elicitation or potentiation of immune responses against the malignancy. Attenuated vaccines are approved and marketed as good manufactiring practice (GMP)-manufactured agents whose administration might be able to induce such effects. Recent reports in mouse transplantable tumor models indicate that the rotavirus, influenza and yellow fever vaccines can be especially suitable to elicit powerful antitumor immunity against cancer following intratumoral administration. These results highlight that intratumoral anti-infectious vaccines can turn cold tumors into hot, and underscore the key role played by virus-induced type I interferon pathways to overcome resistance to immune checkpoint-targeted antibodies.<\/jats:p>","DOI":"10.1136\/jitc-2019-000443","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T04:35:10Z","timestamp":1582691710000},"page":"e000443","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Repurposing infectious disease vaccines for intratumoral immunotherapy"],"prefix":"10.1136","volume":"8","author":[{"suffix":"PhD","given":"Ignacio","family":"Melero","sequence":"first","affiliation":[{"name":"Inmunology and Immunotherapy department, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA) Avda Pio XII, 55 31008, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gato","sequence":"additional","affiliation":[{"name":"Inmunology and Immunotherapy department, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA) Avda Pio XII, 55 31008, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala","family":"Shekarian","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Canc\u00e9rologie de Lyon (CRCL), UMR INSERM U1052 CNRS 5286 Centre de Lutte contre le Cancer L\u00e9on B\u00e9rard, Universit\u00e9 de Lyon, 69008, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Aznar","sequence":"additional","affiliation":[{"name":"Inmunology and Immunotherapy department, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA) Avda Pio XII, 55 31008, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8764-0825","authenticated-orcid":false,"given":"Sandrine","family":"Valsesia-Wittmann","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Canc\u00e9rologie de Lyon (CRCL), UMR INSERM U1052 CNRS 5286 Centre de Lutte contre le Cancer L\u00e9on B\u00e9rard, Universit\u00e9 de Lyon, 69008, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Caux","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Canc\u00e9rologie de Lyon (CRCL), UMR INSERM U1052 CNRS 5286 Centre de Lutte contre le Cancer L\u00e9on B\u00e9rard, Universit\u00e9 de Lyon, 69008, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Etxeberrria","sequence":"additional","affiliation":[{"name":"Inmunology and Immunotherapy department, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA) Avda Pio XII, 55 31008, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Teijeira","sequence":"additional","affiliation":[{"name":"Inmunology and Immunotherapy department, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA) Avda Pio XII, 55 31008, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelien","family":"Marabelle","sequence":"additional","affiliation":[{"name":"Gustave Roussy, INSERM U1015, Universit\u00e9 Paris-Saclay, Drug Development Department (DITEP), Gustave Roussy, 94805, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"2025100302235949000_8.1.e000443.1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601145"},{"key":"2025100302235949000_8.1.e000443.2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41573-019-0043-2","article-title":"Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles","volume":"18","author":"Vanpouille-Box","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2025100302235949000_8.1.e000443.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0029-0"},{"key":"2025100302235949000_8.1.e000443.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.3377"},{"key":"2025100302235949000_8.1.e000443.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.1529"},{"key":"2025100302235949000_8.1.e000443.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.08.027"},{"key":"2025100302235949000_8.1.e000443.7","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.107"},{"key":"2025100302235949000_8.1.e000443.8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat5025","article-title":"Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade","volume":"11","author":"Shekarian","year":"2019","journal-title":"Sci Transl Med"},{"key":"2025100302235949000_8.1.e000443.9","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/annonc\/mdy423","article-title":"Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)","volume":"29","author":"Marabelle","year":"2018","journal-title":"Ann Oncol"},{"key":"2025100302235949000_8.1.e000443.10","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910375","article-title":"Repurposing the yellow fever vaccine for intratumoral immunotherapy","volume":"12","author":"Aznar","year":"2020","journal-title":"EMBO Mol Med"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2019-000443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:24:07Z","timestamp":1759483447000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2019-000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,2,25]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1136\/jitc-2019-000443"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2019-000443","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}